{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:43:23Z","timestamp":1793112203791,"version":"4.5.0"},"posted":{"date-parts":[[2023,2,3]]},"group-title":"Pharmacology and Toxicology","reference-count":76,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants with myriad adverse effects. While perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are the most common contaminants, levels of replacement PFAS, such as perfluoro-2-methyl-3-oxahexanoic acid (GenX), are increasing. In rodents, PFOA, PFOS, and GenX have several adverse effects on the liver, including nonalcoholic fatty liver disease.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to determine human-relevant mechanisms of PFAS induced adverse hepatic effects using FRG liver-chimeric humanized mice with livers repopulated with functional human hepatocytes.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Male humanized mice were treated with 0.067 mg\/L of PFOA, 0.145 mg\/L of PFOS, or 1 mg\/L of GenX in drinking water for 28 days. Liver and serum were collected for pathology and clinical chemistry, respectively. RNA-sequencing coupled with pathway analysis was used to determine molecular mechanisms.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    PFOS caused a significant decrease in total serum cholesterol and LDL\/VLDL, whereas GenX caused a significant elevation in LDL\/VLDL with no change in total cholesterol and HDL. PFOA had no significant changes in serum LDL\/VLDL and total cholesterol. All three PFAS induced significant hepatocyte proliferation. RNA-sequencing with alignment to the human genome showed a total of 240, 162, and 619 differentially expressed genes after PFOA, PFOS, and GenX exposure, respectively. Upstream regulator analysis revealed inhibition of NR1D1, a transcriptional repressor important in circadian rhythm, as the major common molecular change in all PFAS treatments. PFAS treated mice had significant nuclear localization of NR1D1.\n                    <jats:italic>In silico<\/jats:italic>\n                    modeling showed PFOA, PFOS, and GenX potentially interact with the DNA-binding domain of NR1D1.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>These data implicate PFAS in circadian rhythm disruption via inhibition of NR1D1. These studies show that FRG humanized mice are a useful tool for studying the adverse outcome pathways of environmental pollutants on human hepatocytes in situ.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.02.01.526711","type":"posted-content","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T02:45:18Z","timestamp":1675478718000},"source":"Crossref","is-referenced-by-count":4,"title":["Identifying Human Specific Adverse Outcome Pathways of Per- and Polyfluoroalkyl Substances Using Liver-Chimeric Humanized Mice"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-3112","authenticated-orcid":false,"given":"Dakota R.","family":"Robarts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Paine-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Kotulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn K.","family":"Venneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Gunewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christopher","family":"Corton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lander","family":"Foquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Bial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-7164","authenticated-orcid":false,"given":"Udayan","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2023020610501658000_2023.02.01.526711v1.1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909052925"},{"key":"2023020610501658000_2023.02.01.526711v1.2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/kfz077","article-title":"Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-jun n-terminal kinase","volume":"170","year":"2019","journal-title":"Toxicol Sci"},{"key":"2023020610501658000_2023.02.01.526711v1.3","doi-asserted-by":"crossref","first-page":"152845","DOI":"10.1016\/j.tox.2021.152845","article-title":"Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (pfas) in humans? A workshop report on potential mechanisms","volume":"459","year":"2021","journal-title":"Toxicology"},{"key":"2023020610501658000_2023.02.01.526711v1.4","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080976"},{"key":"2023020610501658000_2023.02.01.526711v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1326"},{"key":"2023020610501658000_2023.02.01.526711v1.6","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.2.175"},{"key":"2023020610501658000_2023.02.01.526711v1.7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2016.05.001","article-title":"The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction","volume":"304","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"2023020610501658000_2023.02.01.526711v1.8","doi-asserted-by":"crossref","first-page":"152565","DOI":"10.1016\/j.tox.2020.152565","article-title":"Early life exposure to per- and polyfluoroalkyl substances (pfas) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects","volume":"443","year":"2020","journal-title":"Toxicology"},{"key":"2023020610501658000_2023.02.01.526711v1.9","doi-asserted-by":"crossref","unstructured":"Brennan NM , Evans AT , Fritz MK , Peak SA , von Holst HE . 2021. Trends in the regulation of per- and polyfluoroalkyl substances (pfas): A scoping review. Int J Environ Res Public Health 18.","DOI":"10.3390\/ijerph182010900"},{"key":"2023020610501658000_2023.02.01.526711v1.10","first-page":"1","article-title":"A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans","volume":"1","year":"2014","journal-title":"Crit Rev Toxicol 44 Suppl"},{"key":"2023020610501658000_2023.02.01.526711v1.11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0192623320905803","article-title":"Assessment of the mode of action underlying the effects of genx in mouse liver and implications for assessing human health risks","volume":"48","year":"2020","journal-title":"Toxicol Pathol"},{"key":"2023020610501658000_2023.02.01.526711v1.12","doi-asserted-by":"crossref","first-page":"107056","DOI":"10.1016\/j.envint.2021.107056","article-title":"Developmental toxicity of nafion byproduct 2 (nbp2) in the sprague-dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (hfpo-da or genx) and perfluorooctane sulfonate (pfos)","volume":"160","year":"2022","journal-title":"Environ Int"},{"key":"2023020610501658000_2023.02.01.526711v1.13","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2013.835784"},{"key":"2023020610501658000_2023.02.01.526711v1.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-017-2094-7"},{"key":"2023020610501658000_2023.02.01.526711v1.15","doi-asserted-by":"crossref","unstructured":"Cunningham ML , Collins BJ , Hejtmancik MR , Herbert RA , Travlos GS , Vallant MK , et al. 2010. Effects of the pparalpha agonist and widely used antihyperlipidemic drug gemfibrozil on hepatic toxicity and lipid metabolism. PPAR Res 2010.","DOI":"10.1155\/2010\/681963"},{"key":"2023020610501658000_2023.02.01.526711v1.16","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4834-3"},{"key":"2023020610501658000_2023.02.01.526711v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2023020610501658000_2023.02.01.526711v1.18","doi-asserted-by":"crossref","first-page":"108648","DOI":"10.1016\/j.envres.2019.108648","article-title":"Human exposure to per- and polyfluoroalkyl substances (pfas) through drinking water: A review of the recent scientific literature","volume":"177","year":"2019","journal-title":"Environ Res"},{"key":"2023020610501658000_2023.02.01.526711v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/etc.4890"},{"key":"2023020610501658000_2023.02.01.526711v1.20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2018.00524","article-title":"Plasmodium falciparum liver stage infection and transition to stable blood stage infection in liver-humanized and blood-humanized frgn ko mice enables testing of blood stage inhibitory antibodies (reticulocyte-binding protein homolog 5) in vivo","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"2023020610501658000_2023.02.01.526711v1.21","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.163"},{"key":"2023020610501658000_2023.02.01.526711v1.22","doi-asserted-by":"crossref","first-page":"38039","DOI":"10.1038\/srep38039","article-title":"Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (pfaas) in occupational workers in china","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"2023020610501658000_2023.02.01.526711v1.23","doi-asserted-by":"crossref","first-page":"105583","DOI":"10.1016\/j.envint.2020.105583","article-title":"Environmental contamination and human exposure to pfass near a fluorochemical production plant: Review of historic and current pfoa and genx contamination in the netherlands","volume":"137","year":"2020","journal-title":"Environ Int"},{"key":"2023020610501658000_2023.02.01.526711v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105358"},{"key":"2023020610501658000_2023.02.01.526711v1.25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.32326","article-title":"Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans","volume":"76","year":"2022","journal-title":"Hepatology"},{"key":"2023020610501658000_2023.02.01.526711v1.26","doi-asserted-by":"crossref","first-page":"118202","DOI":"10.1016\/j.envpol.2021.118202","article-title":"Exposure to genx and its novel analogs disrupts fatty acid metabolism in male mice","volume":"291","year":"2021","journal-title":"Environ Pollut"},{"key":"2023020610501658000_2023.02.01.526711v1.27","doi-asserted-by":"crossref","first-page":"107108","DOI":"10.1016\/j.envint.2022.107108","article-title":"Human exposure to f-53b in china and the evaluation of its potential toxicity: An overview","volume":"161","year":"2022","journal-title":"Environ Int"},{"key":"2023020610501658000_2023.02.01.526711v1.28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/awwa.1073","article-title":"Recently detected drinking water contaminants: Genx and other per- and polyfluoroalkyl ether acids","volume":"110","year":"2018","journal-title":"Journal - AWWA"},{"key":"2023020610501658000_2023.02.01.526711v1.29","doi-asserted-by":"publisher","DOI":"10.1515\/bchm.1997.378.7.651"},{"key":"2023020610501658000_2023.02.01.526711v1.30","doi-asserted-by":"publisher","DOI":"10.1080\/713608372"},{"key":"2023020610501658000_2023.02.01.526711v1.31","doi-asserted-by":"crossref","unstructured":"Kupershmidt I , Su QJ , Grewal A , Sundaresh S , Halperin I , Flynn J , et al. 2010. Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5.","DOI":"10.1371\/journal.pone.0013066"},{"key":"2023020610501658000_2023.02.01.526711v1.32","doi-asserted-by":"crossref","first-page":"151003","DOI":"10.1016\/j.scitotenv.2021.151003","article-title":"Per- and polyfluoroalkyl substances in water and wastewater: A critical review of their global occurrence and distribution","volume":"809","year":"2022","journal-title":"Sci Total Environ"},{"key":"2023020610501658000_2023.02.01.526711v1.33","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2017-104651"},{"key":"2023020610501658000_2023.02.01.526711v1.34","doi-asserted-by":"publisher","DOI":"10.1021\/es2011622"},{"key":"2023020610501658000_2023.02.01.526711v1.35","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"2023020610501658000_2023.02.01.526711v1.36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2017.11.008","article-title":"Efficacy of hepatitis b virus ribonuclease hinhibitors, a new class of replication antagonists, in frg human liver chimeric mice","volume":"149","year":"2018","journal-title":"Antiviral Res"},{"key":"2023020610501658000_2023.02.01.526711v1.37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcmgh.2021.10.007","article-title":"A novel humanized model of nash and its treatment with meta4, a potent agonist of met","volume":"13","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2023020610501658000_2023.02.01.526711v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2010.07.019"},{"key":"2023020610501658000_2023.02.01.526711v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256"},{"key":"2023020610501658000_2023.02.01.526711v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(94)90089-2"},{"key":"2023020610501658000_2023.02.01.526711v1.41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2019.03.020","article-title":"The circadian clock and liver function in health and disease","volume":"71","year":"2019","journal-title":"J Hepatol"},{"key":"2023020610501658000_2023.02.01.526711v1.42","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.10009"},{"key":"2023020610501658000_2023.02.01.526711v1.43","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.1.14"},{"key":"2023020610501658000_2023.02.01.526711v1.44","doi-asserted-by":"crossref","first-page":"117329","DOI":"10.1016\/j.envpol.2021.117329","article-title":"6:2 cl-pfesa has the potential to cause liver damage and induce lipid metabolism disorders in female mice through the action of ppar-gamma","volume":"287","year":"2021","journal-title":"Environ Pollut"},{"key":"2023020610501658000_2023.02.01.526711v1.45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.watres.2013.10.045","article-title":"Behaviour and fate of perfluoroalkyl and polyfluoroalkyl substances (pfass) in drinking water treatment: A review","volume":"50","year":"2014","journal-title":"Water Res"},{"key":"2023020610501658000_2023.02.01.526711v1.46","first-page":"e009","article-title":"The orphan rev-erb nuclear receptors: A link between metabolism, circadian rhythm and inflammation?","volume":"4","year":"2006","journal-title":"Nucl Recept Signal"},{"key":"2023020610501658000_2023.02.01.526711v1.47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/toxsci\/kfab102","article-title":"Potency ranking of per- and polyfluoroalkyl substances using high-throughput transcriptomic analysis of human liver spheroids","volume":"184","year":"2021","journal-title":"Toxicol Sci"},{"key":"2023020610501658000_2023.02.01.526711v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2008.10.006"},{"key":"2023020610501658000_2023.02.01.526711v1.49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jcmgh.2022.01.014","article-title":"Regulation of liver regeneration by hepatocyte o-glcnacylation in mice","volume":"13","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2023020610501658000_2023.02.01.526711v1.50","doi-asserted-by":"crossref","first-page":"153259","DOI":"10.1016\/j.tox.2022.153259","article-title":"Genx induces fibroinflammatory gene expression in primary human hepatocytes","volume":"477","year":"2022","journal-title":"Toxicology"},{"key":"2023020610501658000_2023.02.01.526711v1.51","doi-asserted-by":"crossref","unstructured":"Rogers RD , Reh CM , Breysse P . 2021. Advancing per- and polyfluoroalkyl substances (pfas) research: An overview of atsdr and nceh activities and recommendations. J Expo Sci Environ Epidemiol.","DOI":"10.1038\/s41370-021-00316-6"},{"key":"2023020610501658000_2023.02.01.526711v1.52","doi-asserted-by":"crossref","first-page":"112565","DOI":"10.1016\/j.envres.2021.112565","article-title":"How to investigate human health effects related to exposure to mixtures of per- and polyfluoroalkyl substances: A systematic review of statistical methods","volume":"205","year":"2022","journal-title":"Environ Res"},{"key":"2023020610501658000_2023.02.01.526711v1.53","doi-asserted-by":"crossref","unstructured":"Rosen MB , Schmid JR , Corton JC , Zehr RD , Das KP , Abbott BD , et al. 2010. Gene expression profiling in wild-type and pparalpha-null mice exposed to perfluorooctane sulfonate reveals pparalpha-independent effects. PPAR Res 2010.","DOI":"10.1155\/2010\/794739"},{"key":"2023020610501658000_2023.02.01.526711v1.54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2017.05.013","article-title":"Pparalpha-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling","volume":"387","year":"2017","journal-title":"Toxicology"},{"key":"2023020610501658000_2023.02.01.526711v1.55","doi-asserted-by":"crossref","unstructured":"Rowan-Carroll A , Reardon A , Leingartner K , Gagne R , Williams A , Meier MJ , et al. 2021. High-throughput transcriptomic analysis of human primary hepatocyte spheroids exposed to per- and polyfluoroalkyl substances (pfas) as a platform for relative potency characterization. Toxicol Sci.","DOI":"10.1101\/2020.10.15.341362"},{"key":"2023020610501658000_2023.02.01.526711v1.56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/livers1040017","article-title":"Perfluoroalkyl carboxylic acids interact with the human bile acid transporter ntcp","volume":"1","year":"2021","journal-title":"Livers"},{"key":"2023020610501658000_2023.02.01.526711v1.57","doi-asserted-by":"crossref","first-page":"115644","DOI":"10.1016\/j.taap.2021.115644","article-title":"Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized pparalpha mice fed an american diet","volume":"426","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"2023020610501658000_2023.02.01.526711v1.58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","article-title":"Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"2023020610501658000_2023.02.01.526711v1.59","doi-asserted-by":"publisher","DOI":"10.1021\/bi011086r"},{"key":"2023020610501658000_2023.02.01.526711v1.60","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp279"},{"key":"2023020610501658000_2023.02.01.526711v1.61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2020.11.014","article-title":"Crispr-cas9 gene editing of hepatitis b virus in chronically infected humanized mice","volume":"20","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2023020610501658000_2023.02.01.526711v1.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41370-018-0094-1"},{"key":"2023020610501658000_2023.02.01.526711v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.8"},{"key":"2023020610501658000_2023.02.01.526711v1.64","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfl135"},{"key":"2023020610501658000_2023.02.01.526711v1.65","doi-asserted-by":"publisher","DOI":"10.1177\/0192623314544378"},{"key":"2023020610501658000_2023.02.01.526711v1.66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12885-015-1500-x","article-title":"The truncated splice variant of peroxisome proliferator-activated receptor alpha, pparalpha-tr, autonomously regulates proliferative and pro-inflammatory genes","volume":"15","year":"2015","journal-title":"BMC Cancer"},{"key":"2023020610501658000_2023.02.01.526711v1.67","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"2023020610501658000_2023.02.01.526711v1.68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02550"},{"key":"2023020610501658000_2023.02.01.526711v1.69","doi-asserted-by":"crossref","unstructured":"Umbaugh DS , Soder RP , Nguyen NT , Adelusi O , Robarts DR , Woolbright B , et al. 2022. Human wharton\u2019s jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts. Archives of Toxicology.","DOI":"10.1007\/s00204-022-03372-5"},{"key":"2023020610501658000_2023.02.01.526711v1.70","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00064.2012"},{"key":"2023020610501658000_2023.02.01.526711v1.71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jat.3376","article-title":"Rna-sequencing analysis reveals the hepatotoxic mechanism of perfluoroalkyl alternatives, hfpo2 and hfpo4, following exposure in mice","volume":"37","year":"2017","journal-title":"J Appl Toxicol"},{"key":"2023020610501658000_2023.02.01.526711v1.72","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","article-title":"Human esc-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury","volume":"29","year":"2019","journal-title":"Cell Res"},{"key":"2023020610501658000_2023.02.01.526711v1.73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15022892"},{"key":"2023020610501658000_2023.02.01.526711v1.74","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfn166"},{"key":"2023020610501658000_2023.02.01.526711v1.75","doi-asserted-by":"crossref","first-page":"77004","DOI":"10.1289\/EHP6785","article-title":"Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","year":"2020","journal-title":"Environ Health Perspect"},{"key":"2023020610501658000_2023.02.01.526711v1.76","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfv102"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.02.01.526711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:13:37Z","timestamp":1768450417000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.02.01.526711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1101\/2023.02.01.526711","relation":{},"subject":[],"published":{"date-parts":[[2023,2,3]]},"subtype":"preprint"}}